Actually, the new wave of functional foods or "nutraceuticals" will offer real health benefits, regardless of quality of the marketing, and there will be money to be made for investors.
European food analysts are already alive to this new area, especially Schroders, which has written the definitive report to-date ( May, 1997, 144 pages, "Bridging the Gap Between Foods & Pharmaceuticals" ) and we are seeing the beginnings of US analysts beginning to cover and specialize in this area. For example, Piper Jaffray has a major report out called the "Functional Food Chain", BioScience Securities has a report our called " The creation fo the Food, Health and Wellness Complex", Adams, Harkness & Hill is entering this area of research, John McMillan at Prudential is specializing in this area, Vector Securities has assigned Christine McCracken to cover this area and Rob Mains at Advest has just issued a major report in this area ( Forbes Medi-Tech Strong Buy recommendation ).
You will make money if you get in on the cutting edge of this new technology wave. Food will be used as a drug and healthy natural agent delivery system. |
